THERE HAS BEEN controversy regarding the appropriate use of magnetic resonance (MR) contrast agents in the evaluation of central nervous system (CNS) tumors. When MR imaging was first available in clinical practice in the early 1980s. contrast agents were thought to be unnecessary because of the exc
Quantitative mr imaging data in the evaluation of hepatic metastases during systemic chemotherapy
✍ Scribed by Andrea Giovagnoni; Enrico Paci; Filippo Terilli; Riccardo Cellerino; Andrea Piga
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 553 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1053-1807
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
To identify changes induced by chemotherapy in hepatic metastases, 34 patients with metastases underwent magnetic resonance (MR) imaging before the start of systemic chemotherapy and monthly thereafter. The number, size, and morphologic patterns of the lesions and changes in quantitative parameters (signal‐to‐noise ratio [S/N], contrast‐to‐noise ratio, and signal intensity ratio) were evaluated and correlated with response to treatment and prognosis. After treatment, seven patients showed a partial response, 18 had stable disease, and nine had progressive disease. No relevant changes in the patterns of the lesions were observed. Quantitative data showed that patients with a good prognosis had an increase in S/N on T1‐weighted images and a relative decrease on T2‐weighted images; patients with a poor prognosis showed a decrease in S/N on T1‐weighted images and an increase on T2‐weighted images. The differences between patient groups were significant for both T1‐ and T2‐ weighted images. This study demonstrates the value of MR imaging in follow‐up of liver metastases and suggests the usefulness of quantitative MR imaging data.
📜 SIMILAR VOLUMES
## Abstract ## Purpose To evaluate the potential of a new lipophilic paramagnetic complex [Gd(Bz‐TTDA)]^2–^ [(4s)‐4‐benzyl‐3,6,10‐tri(carboxymethyl)‐3,6,10‐triazadodecandioic acid]^2–^ designed for use as a hepatobiliary MR contrast agent. ## Materials and Methods MR imaging studies for normal a
## Abstract ## BACKGROUND Breast Imaging Reporting and Data System (BI‐RADS) Category 3 represents ‘probably benign’ mammographic abnormalities requiring close follow‐up, but biopsies sometimes are performed on Category 3 abnormalities. Controversy exists as to when these biopsies are justified. T